Navigation Links
Cost Effective Solution for Patient Testing: Introducing Comprehensive and Affordable Molecular Diagnosis With Verifiable Accuracy
Date:8/31/2009

SAN DIEGO, Aug. 31 /PRNewswire/ -- San Diego-based MultiGEN Diagnostics Inc. has launched a novel multi-target DNA sequencing technology (MultiGEN) for a wide range of clinical testing in molecular diagnostics.

"Until now, lack of a single testing platform has resulted in fragmenting the diagnostic market, forcing laboratories to adopt number of alternative methods such as traditional culture, serology and probe based DNA testing," says Dr. Moorthy, President and Founder of MultiGEN Diagnostics. "Present test methods have increased cost of testing, and hence, all clinically relevant targets are not tested routinely. The use of a single, reliable and versatile single-platform technology (MultiGEN) for testing diverse clinical sample unifies testing procedures and reduces cost significantly. MultiGEN's unique features will exceed end-user expectations, and thereby encourage further use of molecular diagnostics in clinical markets."

MultiGEN's patented platform technology allows detection and confirmation of multiple targets simultaneously using unmatched DNA sequencing, while still maintaining the highest possible sensitivity and specificity. These tests include panels for common pathogens causing an infectious syndrome (e.g. STDs - sexually transmitted diseases), acquired mutations in cancer that affect the response to drugs (e.g. K-ras, EGFR mutations for colo-rectal cancer therapy), and genetic predisposition to disease (e.g. Thrombophilia panel with Factor V, Prothrombin, MTHFR for clotting disorders).

Dr. Roger Hodkinson, a clinical pathologist with MultiGEN Diagnostics comments, "MultiGEN is pioneering the concept of 'Syndrome Driven(TM)' test panels for the simultaneous detection of multiple DNA targets". He further adds, "The proprietary test platform has verifiable accuracy, and with its automated off-the-shelf liquid handling systems and genetic analyzers, it enables to decrease the hands-on technical time, minimize human error, and reduce the overall cost."

"MultiGEN Diagnostics accepts a variety of samples for its tests including buccal swabs, and the results are reported within a day. This platform technology is flexible enough to launch new test menus within weeks, and detect ever changing microbial virulence, including H1N1, HIV, and MRSA," says Dr. Linda Wasserman, Medical Director of MultiGen Diagnostics.


'/>"/>
SOURCE MultiGEN Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New treatment effective in counteracting cocaine-induced symptoms
2. Use of certain lipid measures not more effective in predicting coronary heart disease
3. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
4. Effectiveness of mouse breeds that mimic Alzheimers disease symptoms questioned
5. Stanford study highlights cost-effective method of lowering heart disease risks
6. Jefferson specialists studying innovative surgery for effectively treating sleep apnea
7. Case Management Cost-Effective Way to Cut Heart Risks
8. ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008.
9. Nasal Anthrax Vaccine Proves Effective in Animal Study
10. Family-based treatment more effective than supportive psychotherapy in treating bulimia
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... TX (PRWEB) , ... February 12, 2016 , ... ... of southwest Houston and surrounding communities by continuing it’s commitment to act as ... Family Promise. The organization works closely with area homeless families to fulfill immediate ...
(Date:2/12/2016)... ... February 12, 2016 , ... ... Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar that will ... access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C treatment Sovaldi ...
(Date:2/12/2016)... ... February 12, 2016 , ... A lot has been ... years. A president has access to health and wellness resources most Americans could ever ... no single individual has a schedule as frenetic as the U.S. President. , ...
(Date:2/12/2016)... ... February 12, 2016 , ... The aging population ... of long term care. With that, says Patrick Loughney, president of Longtree ... roles in long term care environments. His company, which offers prep courses and ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... 2016 AAIPharma Services Corp./Cambridge Major Laboratories, ... and development services for the pharmaceutical and biotechnology ... capacity in its Charleston, SC ... several recent investments. Charleston ... line with small-scale lyophilization. The site has invested ...
(Date:2/11/2016)... ANKENY, Iowa , 11 de fevereiro de ... a inauguração de sua fábrica de soroalbumina bovina ... Nova Zelândia. A fábrica fica na Ilha Norte ... Loop "), desenvolvido e estabelecido na fábrica da ... Iowa . O projeto e instalação dos ...
(Date:2/11/2016)... Breast Cancer Therapeutics in Asia-Pacific Markets ... (APAC) breast cancer market will experience considerable expansion ... at a Compound Annual Growth Rate (CAGR) of 8.5%. ... - states that the Asia-Pacific ... billion in 2014 to $3.4 billion by 2021, at a ...
Breaking Medicine Technology: